AVROBIO Statistics

Total Valuation

AVROBIO has a market cap or net worth of $53.83 million. The enterprise value is -$43.59 million.

Market Cap	53.83M
Enterprise Value	-43.59M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

AVROBIO has 44.86 million shares outstanding. The number of shares has increased by 1.90% in one year.

Shares Outstanding	44.86M
Shares Change (YoY)	+1.90%
Shares Change (QoQ)	+1.05%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	61.27%
Float	29.54M

Valuation Ratios

The trailing PE ratio is 4.44.

PE Ratio	4.44
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.57
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.78, with a Debt / Equity ratio of 0.01.

Current Ratio	15.78
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	0.07
Debt / FCF	n/a
Interest Coverage	-4.18

Financial Efficiency

Return on equity (ROE) is 13.00% and return on invested capital (ROIC) is 10.34%.

Return on Equity (ROE)	13.00%
Return on Assets (ROA)	11.30%
Return on Capital (ROIC)	10.34%
Revenue Per Employee	n/a
Profits Per Employee	$935,154
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AVROBIO has paid $377,000 in taxes.

Income Tax	377,000
Effective Tax Rate	3.01%

Stock Price Statistics

The stock price has increased by +33.32% in the last 52 weeks. The beta is 1.24, so AVROBIO's price volatility has been higher than the market average.

Beta (1Y)	1.24
52-Week Price Change	+33.32%
50-Day Moving Average	1.28
200-Day Moving Average	1.40
Relative Strength Index (RSI)	36.62
Average Volume (30 Days)	294,280

Short Selling Information

The latest short interest is 143,196, so 0.32% of the outstanding shares have been sold short.

Short Interest	143,196
Short Previous Month	124,984
Short % of Shares Out	0.32%
Short % of Float	0.48%
Short Ratio (days to cover)	0.69

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	10.19M
Pretax Income	12.53M
Net Income	12.16M
EBITDA	12.64M
EBIT	10.11M
Earnings Per Share (EPS)	$0.27

Full Income Statement

Balance Sheet

The company has $98.30 million in cash and $878,000 in debt, giving a net cash position of $97.43 million or $2.17 per share.

Cash & Cash Equivalents	98.30M
Total Debt	878,000
Net Cash	97.43M
Net Cash Per Share	$2.17
Equity / Book Value	94.74M
Book Value Per Share	2.11
Working Capital	93.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.19 million and capital expenditures $1.34 million, giving a free cash flow of -$61.85 million.

Operating Cash Flow	-63.19M
Capital Expenditures	1.34M
Free Cash Flow	-61.85M
FCF Per Share	-$1.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVROBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.90%
Shareholder Yield	-1.90%
Earnings Yield	22.58%
FCF Yield	-114.89%

Analyst Forecast

The average price target for AVROBIO is $2.00, which is 66.67% higher than the current price. The consensus rating is "Hold".

Price Target	$2.00
Price Target Difference	66.67%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3